| Outcome and approval process; no. of drugs approved | ||||||
|---|---|---|---|---|---|---|
| Therapeutic indication | Clinical outcome | Surrogate outcome | ||||
| Standard | Priority | NOC/c | Standard | Priority | NOC/c | |
| Allergy | 3 | 0 | 0 | 0 | 0 | 0 |
| Cancer | 7 | 9 | 0 | 15 | 9 | 12 |
| Cardiovascular | 2 | 2 | 0 | 5 | 0 | 1 |
| Dermatology | 6 | 0 | 0 | 0 | 0 | 0 |
| Genitourinary | 6 | 0 | 0 | 0 | 0 | 0 |
| Gastrointestinal | 6 | 1 | 0 | 0 | 0 | 0 |
| Gynecology | 2 | 0 | 0 | 1 | 0 | 0 |
| Hematology | 5 | 0 | 0 | 4 | 2 | 1 |
| Inborn error of metabolism | 0 | 1 | 0 | 3 | 2 | 0 |
| Infectious disease, hepatitis | 0 | 0 | 0 | 0 | 6 | 0 |
| Infectious disease, HIV | 0 | 0 | 0 | 4 | 2 | 3 |
| Infectious disease, other | 12 | 2 | 1 | 0 | 0 | 0 |
| Infectious disease, vaccine | 3 | 1 | 0 | 6 | 2 | 0 |
| Metabolic disease, diabetes | 0 | 0 | 0 | 9 | 0 | 0 |
| Metabolic disease, other | 0 | 0 | 0 | 10 | 3 | 0 |
| Miscellaneous | 6 | 1 | 0 | 0 | 0 | 1 |
| Musculoskeletal | 3 | 0 | 0 | 0 | 0 | 0 |
| Neurology | 16 | 1 | 0 | 1 | 0 | 0 |
| Ophthalmology | 2 | 2 | 0 | 2 | 1 | 0 |
| Psychiatry | 13 | 0 | 0 | 0 | 0 | 0 |
| Pulmonary hypertension | 1 | 1 | 0 | 2 | 1 | 0 |
| Respirology | 2 | 0 | 0 | 5 | 1 | 0 |
| Rheumatology | 6 | 1 | 0 | 0 | 0 | 0 |
| Total | 101 | 22 | 1 | 67 | 29 | 18 |
Note: NOC/c = Notice of Compliance with conditions.